Testing a Thyroid Nodule Gene Assay in People With Uncertain Thyroid Results
Checks how well a genetic test predicts whether unclear thyroid nodules are cancerous.
Plain-language title generated from the registry record
Registry title: To Perform a Post-market Study of the Performance of the Idylla ThyroidPrint Assay Using Clinical Samples in Predicting the Nature of Indeterminate Thyroid Nodules (ITNs) Across Multiple Centers.
Key facts
- Where
- Truro, United KingdomSee the site
Where in United Kingdom
- Royal Cornwall HospitalTruro, United KingdomTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Royal Cornwall Hospitals Trust
- Trial code
- NCT06849284
- Record updated
- 4 June 2025
- Original description
To perform a post-market study of the performance of the Idylla™ ThyroidPrint® Assay using clinical samples in predicting the nature of indeterminate thyroid nodules (ITNs) across multiple centers.Read full original descriptionShow less
Idylla™ ThyroidPrint® RUO Assay Beta-Trial Study
To perform a post-market study of the performance of the Idylla™ ThyroidPrint® Assay using clinical samples in predicting the nature of indeterminate thyroid nodules (ITNs) across multiple centers.
Inclusion: Thyroid nodule ≥1.0 cm; With indeterminate cytology; Surgery due to be performed.
Exclusion: Patients with ultrasound evidence of malignant cervical adenopathy; Specimens which fail to meet the inclusion criteria; FNA fixed in formalin or transferred in alcohol-based collection buffers which is not according to the protocol instructions; RNA extracts.